LYPLAL1 and neoplasm: Our findings provide a comprehensive understanding of the molecular mechanisms through which exosomal LYPLAL1-DT facilitates crosstalk between tumor cells and endothelial cells, promoting malignant phenotypes and vascular remodeling in SCLC.